Immunohistochemical expression of anti-CD68 antibody in atherosclerotic plaque

Romanian Journal of Morphology and Embryology

Volumn 53, Issue 1, 2012, Pages 61-66

  Cojocaru, Elena ^a   Trandafirescu, Mioara ^a   Leon, Magda ^a   Cotutiu C ^a   Foia, Liliana ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Anti CD68 antibody; Arteries; Atherosclerosis; Lesions; Macrophages

Indexed keywords

CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOSYNTHESIS; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; ENDARTERECTOMY; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; INTIMA; MACROPHAGE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ATHEROSCLEROSIS; CELL PROLIFERATION; ENDARTERECTOMY; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; RETROSPECTIVE STUDIES; TUNICA INTIMA;

EID: 84857978844     PISSN: 12200522     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Depairon M, Hayoz D, Darioli R, Early detection of atherosclerosis, Rev Med Suisse, 2006, 2(51):330-332, 335-336.
2. Rosin BL, The progression of cardiovascular risk to cardiovascular disease, Rev Cardiovasc Med, 2007, 8(Suppl 4):S3-S8.
3. Ley K, Miller YI, Hedrick CC, Monocyte and macrophage dynamics during atherogenesis, Arterioscler Thromb Vasc Biol, 2011, 31(7):1506-1516.
4. Murray PJ, Wynn TA, Protective and pathogenic functions of macrophage subsets, Nat Rev Immunol, 2011, 11(11):723-737.
5. Chawla A, Nguyen KD, Goh YP, Macrophage-mediated inflammation in metabolic disease, Nat Rev Immunol, 2011, 11(11):738-749.
6. th edition, Elsevier Saunders, Philadelphia, 2005.
7. Bobryshev YV, Monocyte recruitment and foam cell formation in atherosclerosis, Micron, 2006, 37(3):208-222.
8. Webb NR, Moore KJ, Macrophage-derived foam cells in atherosclerosis: lessons from murine models and implications for therapy, Curr Drug Targets, 2007, 8(12):1249-1263.
9. Boyle JJ, Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture, Curr Vasc Pharmacol, 2005, 3(1):63-68.
10. Ulbrich H, Eriksson EE, Lindbom L, Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease, Trends Pharmacol Sci, 2003, 24(12):640-647.
11. Braunersreuther V, Mach F, Steffens S, The specific role of chemokines in atherosclerosis, Thromb Haemost, 2007, 97(5):714-721.
12. Schulz C, Schäfer A, Stolla M, Kerstan S, Lorenz M, von Brühl ML, Schiemann M, Bauersachs J, Gloe T, Busch DH, Gawaz M, Massberg S, Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets, Circulation, 2007, 116(7):764-773.
13. McLaren JE, Michael DR, Ashlin TG, Ramji DP, Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy, Prog Lipid Res, 2011, 50(4):331-347.
14. Moore KJ, Tabas I, Macrophages in the pathogenesis of atherosclerosis, Cell, 2011, 145(3):341-355.
15. Bui QT, Prempeh M, Wilensky RL, Atherosclerotic plaque development, Int J Biochem Cell Biol, 2009, 41(11):2109-2113.
16. Loppnow H, Werdan K, Buerke M, Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms, Innate Immun, 2008, 14(2):63-87.
17. Holvoet P, Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease, Verh K Acad Geneeskd Belg, 2008, 70(3):193-219.
18. Matoba T, Egashira K, Anti-inflammatory gene therapy for cardiovascular disease, Curr Gene Ther, 2011, 11(6).
19. Shi C, Pamer EG, Monocyte recruitment during infection and inflammation, Nat Rev Immunol, 2011, 11(11):762-774.
20. Wolfs IM, Donners MM, de Winther MP, Differentiation factors and cytokines in the atherosclerotic plaque microenvironment as a trigger for macrophage polarization, Thromb Haemost, 2011, 106(5):763-771.
21. El Khatib N, Genieys S, Kazmierczak B, Volpert V, Reaction- diffusion model of atherosclerosis development, J Math Biol, 2011 Aug 21.
22. Takahashi K, Takeya M, Sakashita N, Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals, Med Electron Microsc, 2002, 35(4):179-203.
23. Ikonomidis I, Stamatelopoulos K, Lekakis J, Vamvakou GD, Kremastinos DT, Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease, Atherosclerosis, 2008, 199(1):3-11.
24. Ingersoll MA, Platt AM, Potteaux S, Randolph GJ, Monocyte trafficking in acute and chronic inflammation, Trends Immunol, 2011, 32(10):470-477.
25. Palinski W, Witztum JL, Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis, J Intern Med, 2000, 247(3): 171-180.
26. Hansson GK, Hermansson A, The immune system in atherosclerosis, Nat Immunol, 2011, 12(3):204-212.
27. Adamson S, Leitinger N, Phenotypic modulation of macrophages in response to plaque lipids, Curr Opin Lipidol, 2011, 22(5):335-342.